[Long-term treatment of chronic glaucoma with timolol drops: results after four years (author's transl)].
Thirty patients with chronic glaucoma or chronic ocular hypertension were administered Timolol drops for thirty-eight to forty-nine months. Twenty four eyes had their intra-ocular pressure controlled with Timolol alone, during this period, and eighteen eyes with additional treatment (cholinergic agents or sulfonamides). In two cases, temporary superficial punctate keratopathy developed.
D000328:Adult; D000368:Aged; D002257:Carbonic Anhydrase Inhibitors / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005902:Glaucoma, Open-Angle / Q000188:drug therapy*; D006801:Humans; D007634:Keratitis / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D008916:Miotics / Q000627:therapeutic use; D009883:Ophthalmic Solutions; D011412:Propanolamines / Q000627:therapeutic use*; D013997:Time Factors; D013999:Timolol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D002257:Carbonic Anhydrase Inhibitors; D008916:Miotics; D009883:Ophthalmic Solutions; D011412:Propanolamines; D013999:Timolol
Quatre ans de traitement prolongé des glaucomes chroniques par le collyre timolol.